Form DEFA14A Beam Therapeutics Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
|
|
|
|
|
|
☐ |
|
Preliminary Proxy Statement |
|
|
|
☐ |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
|
☐ |
|
Definitive Proxy Statement |
|
|
|
☒ |
|
Definitive Additional Materials |
|
|
|
☐ |
|
Soliciting Material under §240.14a-12 |
BEAM THERAPEUTICS INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement if other than Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
|
|
|
|
|
|||
☒ |
|
No fee required. |
||
|
|
|||
|
|
|||
☐ |
|
Fee paid previously with preliminary materials. |
||
|
|
|||
☐ |
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
||
|
|
|
||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- San Diego's Largest Community-Powered Cancer Research Fundraiser Returns: Curebound Cancer Challenge to Accelerate Cures
- United Solar Holding Inc. Appoints Todd Templeton as Director of the Americas
- United Solar Secures IFC's Backing for FEOC-Compliant Polysilicon, Completing $1.6 Billion Capital Raise
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
